ACHIEVE-5 tested the oral GLP-1 drug in combination with a basal insulin regimen ...

HDV-Insulin Lispro (HDV-LIS) met A1C non-inferiority at Weeks 12 and 25, confirming comparable glycemic control to insulin lispro (LIS) with point-estimate differences below FDA-required 0.1% ...

A large proportion of people living with type 2 diabetes treated with basal insulin therapy remain inadequately controlled ...

First-ever type 2 diabetes and obesity phase 3 study results for retatrutide, a novel glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1(GLP-1), and glucagon triple hormone ...

Today millions of diabetic patients across the world do not have access to insulin. Why and how can governments reverse this ...

This year, Diabetes Week is highlighting the need to change how we talk about diabetes. For the 6 million living with ...

Share on Pinterest A new study found that intermittent fasting could help people with type 2 diabetes lose weight and lower blood sugar levels. FG Trade/Getty Images A study compared 5:2 intermittent ...

Diabetes prevalence in U.S. adults over the past decade has remained stable, with a small non-significant increase. HbA1c and rates of glycemic control significantly worsened from 2017-2020 to ...

Learn how Apple Watch supports diabetes management with CGM glucose readings, Apple Health records, medication reminders, ...

Dihydropyridine calcium-channel-blockers (DCCBs), used to treat high blood pressure, could speed up the progression of kidney ...